Top Medical News

FDA Approves Frontline Pembrolizumab for HER2+ Gastric, GEJ Cancer

May 5th 2021

The FDA granted an accelerated approval to pembrolizumab plus trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for the frontline treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.

Reduce Recurrence in Early-Stage NSCLC

May 5th 2021

Edward S. Kim, MD, highlights the impact of osimertinib in the treatment of patients with EGFR-mutant non–small cell lung cancer, next steps with the agent, and the importance of early genetic testing to provide personalized care.

Expert Talks Ethics in Oncology Nursing

May 4th 2021

Knowing your patient’s beliefs and goals is key to providing ethical cancer care.

Rolling Submission Completed for Surufatinib to Treat Advanced NETs

May 4th 2021

The rolling submission of a new drug application to the FDA for surufatinib for the treatment of patients with pancreatic and non-pancreatic neuroendocrine tumors has been completed.

NP Fellowship Helps Prepare Providers for Oncology Career

May 3rd 2021

Nurse practitioners are more valuable than ever in the world of cancer care.


Most Recent